In B-lymphoma cells and murine models, the muting of CREBBP/EP300 in tumor cells resulted in polarization of TAMs towards the M2 phenotype by activating the NOTCH signaling pathway and downstream CCL2/CSF1 axis [20]. The gene discussed is CCL2; the disease is neoplasm.